Immix Biopharma, Inc.

Immix Biopharma, Inc. - ROEverified

IMMX

Price:

$8.72

Market Cap:

$474.38M

Immix Biopharma, Inc. is a clinical-stage biotechnology firm dedicated to creating a range of tissue-specific therapies. Operating in both the United States and Australia, their primary focus areas are oncology (cancer) and inflammatory diseases. Their product pipeline includes IMX-110, which is currently undergoing Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and various solid tumors. They are also developing IMX-111, a targeted biologic agent for colorectal cancers, and IMX-120, another tissue-specific biologic designed to address ulcerative colitis and severe Crohn's disease. In a strategic move, the company has forged a clinical collaboration and supply agreement ...[Read more]

Industry

Biotechnology

IPO Date

2021-12-16

Stock Exchange

NASDAQ

Ticker

IMMX

The ROE as of June 2026 (TTM) for Immix Biopharma, Inc. (IMMX) is -73.23%

According to Immix Biopharma, Inc.’s latest financial reports and current stock price. The company's current ROE is -73.23%. This represents a change of 13.78% compared to the average of -64.37% of the last 4 quarters.

Immix Biopharma, Inc. (IMMX) Historical ROE (quarterly & annually)

How has IMMX ROE performed in the past?

The mean historical ROE of Immix Biopharma, Inc. over the last ten years is -62.24%. The current -73.23% ROE has changed 17.67% with respect to the historical average. Over the past ten years (40 quarters), IMMX's ROE was at its highest in in the March 2021 quarter at 21.49%. The ROE was at its lowest in in the June 2025 quarter at -142.33%.

Quarterly (TTM)
Annual

Average

-62.24%

Median

-62.54%

Minimum

-163.11%

Maximum

26.68%

Immix Biopharma, Inc. (IMMX) ROE by Quarter and Year

Discovering the peaks and valleys of Immix Biopharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 73.46%

Maximum Annual ROE = 26.68%

Minimum Annual Increase = -658.59%

Minimum Annual ROE = -163.11%

Quarterly (TTM)
Annual
YearROEChange
2025-31.39%-80.76%
2024-163.11%73.46%
2023-94.03%50.36%
2022-62.54%-53.86%
2021-135.54%-658.59%
202024.26%-9.05%

Immix Biopharma, Inc. (IMMX) Average ROE

How has IMMX ROE performed in the past?

The current ROE of Immix Biopharma, Inc. (IMMX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-96.17%

5-year avg

-97.32%

10-year avg

-62.24%

Immix Biopharma, Inc. (IMMX) ROE vs. Peers

How is IMMX’s ROE compared to its peers?

Immix Biopharma, Inc.’s ROE is greater than Coya Therapeutics, Inc. (-57.26%), greater than Whitehawk Therapeutics Inc (-79.63%), less than Oncolytics Biotech Inc. (5.21%), greater than Zentalis Pharmaceuticals, Inc. (-53.61%), less than Surrozen, Inc. (309.79%), greater than Atossa Therapeutics, Inc. (-84.91%), greater than Instil Bio, Inc. (-39.76%), greater than Pliant Therapeutics, Inc. (-59.06%), greater than MacroGenics, Inc. (-147.80%), less than Oramed Pharmaceuticals Inc. (55.29%),

Build a custom stock screener for Immix Biopharma, Inc. (IMMX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immix Biopharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Immix Biopharma, Inc. (IMMX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Immix Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Immix Biopharma, Inc.'s ROE?

How is the ROE calculated for Immix Biopharma, Inc. (IMMX)?

What is the highest ROE for Immix Biopharma, Inc. (IMMX)?

What is the 3-year average ROE for Immix Biopharma, Inc. (IMMX)?

What is the 5-year average ROE for Immix Biopharma, Inc. (IMMX)?

How does the current ROE for Immix Biopharma, Inc. (IMMX) compare to its historical average?